- ►annals.org DR Anderson, BJ O'Brien, MN Levine, R … - Annals of internal medicine, 1993 - Am Coll Physicians Data Identification: Studies were identified by MEDLINE search and review of
bibliographies of retrieved articles. Hospital resources used in treating deep
vein thrombosis and bleeding complications after total hip arthroplasty ... Cited by 128 - Related articles - BL Direct - All 4 versions
J Menzin, GA Colditz, MM Regan, RE Richner, … - Archives of Internal Medicine, 1995 - archinte.highwire.org Page 1. Cost-effectiveness of Enoxaparin vs Low-Dose Warfarin in the Prevention
of Deep-Vein Thrombosis After Total Hip Replacement Surgery ... Cited by 96 - Related articles - BL Direct - All 5 versions
- ►nih.gov [PDF] BJ O'brien, DR Anderson, R Goeree - CMAJ: Canadian Medical Association Journal, 1994 - pubmedcentral.nih.gov Objective: To compare the efficacy and cost-effectiveness of enoxaparin, a
low-molecular- weight heparin derivative, with that of low-dose warfarin in the
prevention of deep-vein thrombosis (DVT) after total hip replacement. Data ... Cited by 91 - Related articles - BL Direct - All 14 versions
M Drummond, M Aristides, L Davies, C Forbes - British Journal of Surgery, 1994 - interscience.wiley.com Deep vein thrombosis (DVT) is a common complication in patients undergoing
elective hip surgery. Because of the associated risk of pulmonary embolism,
prophylaxis with standard (unfractionated) heparin is becoming increasingly ... Cited by 59 - Related articles - BL Direct - All 3 versions
MN Levine, J Hirsh, M Gent, AG Turpie, J … - Annals of internal medicine, 1991 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To determine the relative efficacy and safety of low molecular ... Cited by 213 - Related articles - All 3 versions
RD Hull, GE Raskob, GF Pineo, W Feldstein, D … - Archives of Internal Medicine, 1997 - archinte.highwire.org Results: Deep vein thrombosis was documented in 231 (37.4%) of617 patients
givenwarfarin and in 185 (31.4%) of 590 patients given low-molecular-weight
heparin (P=.03). In Canada, warfarin and low-molecular-weight heparin ( ... Cited by 89 - Related articles - BL Direct - All 6 versions
M Dechavanne, D Ville, M Berruyer, F Trepo, F … - Haemostasis, 1989 - content.karger.com 124 patients undergoing total hip replacement were randomly allocated to receive
Kabi 2165, 2,500 anti-Xa units twice a day (group A); Kabi 2165, 2,500 anti-Xa
units twice a day during the first 48 h postoperatively and then 5,000 ... Cited by 87 - Related articles - All 5 versions
LN Jørgensen, P Wille-Jørgensen, O Hauch… - British Journal of Surgery, 1993 - oc.lm.ehu.es To evaluate the thromboproph}'lactic use of 1011' molecular 11!eight heparins
(LMWHs), publications fi"om 27 orthopaedic trials -and 35 studies of patients
undergou1g general or gynaecological surgerj' 11'ere scrutulized and ... Cited by 121 - Related articles - View as HTML - BL Direct - All 5 versions
- ►annals.org JR Leclerc, WH Geerts, L Desjardins, GH … - Annals of internal medicine, 1996 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To compare the effectiveness and safety of fixed-dose enoxaparin ... Cited by 163 - Related articles - BL Direct - All 5 versions
A Planes, N Vochelle, F Mazas, C Mansat, J … - Thrombosis and haemostasis, 1988 - ncbi.nlm.nih.gov A double blind randomized trial comparing subcutaneous enoxaparin (40 mg once
daily) with standard unfractionated calcium heparin administered at a dose of
5,000 units every 8 hours in patients undergoing elective hip replacement ... Cited by 164 - Related articles
